Glenmark Pharmaceuticals balance sheet

As of Mar 2026

Total assets: ₹19,908cr+24.0% on Mar 2025
Shareholders' equity: ₹10,512cr+18.8% on Mar 2025
Total debt: ₹0.0cr−100.0% on Mar 2025
Cash and investments: ₹1,175cr−29.9% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets					FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	3,890	3,319	3,118	3,904
	428	542	419	1,115
	82.9	70.3	67.4	73.6
	1,942	1,097	1,025	2,225
	481	293	243	136
	42.4	56.4	790	44.7
	67.5	0.0	0.0	0.0
	—	72.9	69.9	39.9
	110	129	860	84.5
	1,247	1,124	1,050	1,806
	428	179	149	154
	8,608	6,754	6,931	9,498
	3,431	3,029	2,513	2,978
	4,963	3,342	1,858	4,099
	1,175	1,676	1,658	1,443
	1.5	29.5	1.2	26.7
	225	62.4	174	174
	6,364	5,110	3,691	5,742
	1,505	1,157	1,224	1,154
	11,300	9,295	7,428	9,874
	19,908	16,050	14,359	19,372
Equity
	28.2	28.2	28.2	28.2
	10,484	8,821	7,820	9,446
	10,512	8,849	7,848	9,474
	−0.3	−0.4	−0.4	365
	10,512	8,849	7,848	9,839
Liabilities
	0.0	513	0.0	3,852
	1,482	662	539	396
	1,482	1,175	691	4,443
	1.2	58.6	0.3	42.9
	1,536	0.0	1.7	1.3
	3,020	1,233	692	4,487
	0.0	1,681	991	496
	3,744	2,580	2,536	2,392
	606	883	1,116	1,350
	4,350	5,144	4,642	4,238
	1,070	596	641	508
	94.5	28.4	291	106
	862	199	244	195
	6,376	5,967	5,819	5,046
	9,396	7,200	6,511	9,532
	19,908	16,050	14,359	19,372
Assets — additional as-filed lines
	0.0	1,157	0.0	0.0
Liabilities — additional as-filed lines
	—	0.0	152	194
Trade payables — MSME split
	23.1	21.4	—	—
	3,721	2,558	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

GLENMARK₹2,300.00

Glenmark Pharmaceuticals Ltd.

· Pharma & Health

₹ CrorePeersDRREDDY LUPIN ALKEM BIOCON MANKIND LAURUSLABS FORTIS AUROPHARMAMcap ₹64,906 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	3,904.2	3,118.2	3,319.4	3,889.6	3,889.6
+ Capital Work-in-Progress	1,115.2	419.3	542.0	427.9	427.9
+ Goodwill	73.6	67.4	70.3	82.9	82.9
+ Other Intangibles	2,224.6	1,024.7	1,097.2	1,942.1	1,942.1
+ Intangibles under Development	136.1	242.6	292.8	481.3	481.3
+ Non-current Investments	44.7	789.7	56.4	42.4	42.4
+ Long-term Loans	0.0	0.0	0.0	67.5	67.5
+ Other Non-current Financial Assets	39.9	69.9	72.9	—	—
Non-current Financial Assets	84.5	859.5	129.3	109.9	109.9
+ Deferred Tax Assets	1,805.9	1,049.7	1,124.1	1,246.6	1,246.6
+ Other Non-current Assets	153.9	149.2	179.0	428.0	428.0
Total Non-current Assets	9,498.0	6,930.5	6,754.1	8,608.2	8,608.2
Current Assets
+ Inventories	2,977.8	2,513.1	3,028.5	3,430.8	3,430.8
+ Trade Receivables	4,098.6	1,858.4	3,341.9	4,963.4	4,963.4
+ Cash & Cash Equivalents	1,443.0	1,658.3	1,675.7	1,174.7	1,174.7
+ Other Bank Balances	26.7	1.2	29.5	1.5	1.5
+ Other Current Financial Assets	174.0	173.6	62.4	224.7	224.7
Current Financial Assets	5,742.3	3,691.5	5,109.6	6,364.3	6,364.3
+ Other Current Assets	1,153.6	1,223.6	1,157.3	1,504.6	1,504.6
Total Current Assets	9,873.7	7,428.1	9,295.5	11,299.7	11,299.7
Total Assets	19,371.7	14,358.6	16,049.6	19,907.9	19,907.9
Equity
+ Equity Share Capital	28.2	28.2	28.2	28.2	28.2
+ Other Equity / Reserves	9,445.7	7,819.7	8,821.2	10,483.9	10,483.9
Equity — Owners of Parent	9,473.9	7,847.9	8,849.4	10,512.1	10,512.1
+ Minority Interest	365.3	-0.4	-0.4	-0.3	-0.3
Total Equity	9,839.3	7,847.5	8,849.1	10,511.8	10,511.8
Liabilities
+ Borrowings — Non-current	3,852.1	0.0	512.7	0.0	0.0
+ Other Non-current Financial Liab	396.3	538.8	662.2	1,482.3	1,482.3
Non-current Financial Liabilities	4,442.6	690.5	1,174.9	1,482.3	1,482.3
+ Deferred Tax Liabilities	42.9	0.3	58.6	1.2	1.2
+ Other Non-current Liabilities	1.3	1.7	0.0	1,536.1	1,536.1
Non-current Liabilities	4,486.9	692.5	1,233.5	3,019.7	3,019.7
+ Borrowings — Current	495.6	990.6	1,681.5	0.0	0.0
+ Trade Payables	2,391.9	2,535.9	2,579.5	3,743.9	3,743.9
+ Other Current Financial Liab	1,350.2	1,115.6	882.5	605.8	605.8
Current Financial Liabilities	4,237.6	4,642.1	5,143.6	4,349.7	4,349.7
+ Provisions — Current	507.5	641.1	596.1	1,070.1	1,070.1
+ Current Tax Liabilities	105.6	291.0	28.4	94.5	94.5
+ Other Current Liabilities	194.8	244.4	199.0	862.1	862.1
Current Liabilities	5,045.5	5,818.6	5,967.0	6,376.4	6,376.4
Total Liabilities	9,532.4	6,511.1	7,200.5	9,396.1	9,396.1
Total Equity & Liabilities	19,371.7	14,358.6	16,049.6	19,907.9	19,907.9
Assets — additional as-filed lines
+ Current Tax Assets	0.0	0.0	1,157.3	0.0	0.0
Liabilities — additional as-filed lines
+ Trade Payables — Non-current	194.2	151.7	0.0	—	—
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	21.4	23.1	23.1
+ Dues to Other Creditors — Current	—	—	2,558.1	3,720.8	3,720.8

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.